PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Texas Instruments Incorporated (TXN)
205.980.01 (0.00%)
205.24 - 207.41
139.95 - 221.69
4.54M / 6.54M (Avg.)
37.59 | 5.48
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
1.65%
Revenue growth 1.25-1.5x ADI's 1.17%. Bruce Berkowitz would check if differentiation or pricing power justifies outperformance.
5.39%
Gross profit growth above 1.5x ADI's 1.68%. David Dodd would confirm if the company's business model is superior in terms of production costs or pricing.
44.97%
Positive EBIT growth while ADI is negative. John Neff might see a substantial edge in operational management.
40.47%
Positive operating income growth while ADI is negative. John Neff might view this as a competitive edge in operations.
75.78%
Net income growth above 1.5x ADI's 4.22%. David Dodd would check if a unique moat or cost structure secures superior bottom-line gains.
78.95%
EPS growth above 1.5x ADI's 3.64%. David Dodd would review if superior product economics or effective buybacks drive the outperformance.
76.32%
Diluted EPS growth above 1.5x ADI's 5.66%. David Dodd would see if there's a robust moat protecting these shareholder gains.
-0.88%
Share reduction while ADI is at 0.11%. Joel Greenblatt would see if the company has a better buyback policy than the competitor.
-1.13%
Both reduce diluted shares. Martin Whitman would review each firm’s ability to continue repurchases and manage option issuance.
0.37%
Dividend growth above 1.5x ADI's 0.02%. David Dodd would verify if the firm's cash flow is robust enough for these payouts.
78.07%
Positive OCF growth while ADI is negative. John Neff would see this as a clear operational advantage vs. the competitor.
98.87%
Positive FCF growth while ADI is negative. John Neff would see a strong competitive edge in net cash generation.
128.08%
10Y revenue/share CAGR 1.25-1.5x ADI's 87.56%. Bruce Berkowitz would investigate brand strength or geographical expansion fueling growth.
16.05%
5Y revenue/share CAGR above 1.5x ADI's 7.13%. David Dodd would look for consistent product or market expansions fueling outperformance.
30.73%
3Y revenue/share CAGR at 75-90% of ADI's 35.55%. Bill Ackman would expect new product strategies to close the gap.
221.77%
10Y OCF/share CAGR at 75-90% of ADI's 273.22%. Bill Ackman would demand strategic changes to close the gap in long-term cash generation.
-1.55%
Both show negative mid-term OCF/share growth. Martin Whitman might suspect a challenged environment or large capital demands for both.
60.07%
3Y OCF/share CAGR above 1.5x ADI's 0.66%. David Dodd would confirm if the firm is quickly gaining an operational edge over the competitor.
530.73%
Similar net income/share CAGR to ADI's 561.08%. Walter Schloss would see parallel tailwinds or expansions for both firms.
26.69%
5Y net income/share CAGR at 50-75% of ADI's 50.42%. Martin Whitman might see a shortfall in operational efficiency or brand power.
61.84%
Below 50% of ADI's 153.21%. Michael Burry suspects a steep short-term disadvantage in bottom-line expansion.
55.49%
10Y equity/share CAGR at 75-90% of ADI's 66.44%. Bill Ackman would push for either higher ROE or more earnings retention to catch the competitor.
28.39%
Below 50% of ADI's 69.47%. Michael Burry sees a substantially weaker mid-term book value expansion strategy in place.
34.19%
3Y equity/share CAGR at 50-75% of ADI's 60.00%. Martin Whitman sees a short-term lag in net worth creation vs. the competitor.
707.91%
Dividend/share CAGR of 707.91% while ADI is zero. Bruce Berkowitz sees a slight advantage in stepping up payouts steadily.
113.40%
5Y dividend/share CAGR above 1.5x ADI's 63.15%. David Dodd checks if the firm's mid-term cash flows justify a faster dividend growth rate.
56.13%
3Y dividend/share CAGR 1.25-1.5x ADI's 50.01%. Bruce Berkowitz checks if the company's short-term profits or payout policy justify these higher hikes.
-0.37%
Firm’s AR is declining while ADI shows 4.70%. Joel Greenblatt sees stronger working capital efficiency if sales hold up.
-1.96%
Inventory is declining while ADI stands at 2.74%. Joel Greenblatt sees potential cost and margin benefits if sales hold up.
5.09%
Asset growth above 1.5x ADI's 0.82%. David Dodd checks if M&A or new capacity expansions are value-accretive vs. competitor's approach.
3.10%
1.25-1.5x ADI's 2.53%. Bruce Berkowitz sees if the firm's capital management strategies surpass the competitor's approach.
20.99%
We have some new debt while ADI reduces theirs. John Neff sees the competitor as more cautious unless our expansions pay off strongly.
-3.54%
Our R&D shrinks while ADI invests at 1.69%. Joel Greenblatt checks if we risk falling behind a competitor’s new product pipeline.
-0.66%
Both reduce SG&A yoy. Martin Whitman sees a cost war or cyclical slowdown forcing overhead cuts.